Health System CEOs Meet with RFK Jr. and Encourage Him to Preserve and Strengthen 340B at HHS Roundtable 

The CEOs of Cincinnati’s Bon Secours Mercy Health, Cleveland-based University Hospitals, Kansas-based HaysMed and Minnesota’s Riverwood Healthcare Center met with HHS Secretary Robert F. Kennedy Jr. last week. (Photo courtesy: Kennedy's X post.)
The leaders of four health systems recently met with Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS Continues to Oppose Unapproved Drugmaker 340B Rebate Models in New Legal Filings

HHS has again urged a federal district court to reject multiple drug industry lawsuits seeking to implement 340B rebate models.
The U.S. Department of Health and Human Services (HHS) is continuing its pushback against drugmaker attempts to unilaterally convert upfront [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Should We Prepare for a 340B Rebate Model?

SPONSORED CONTENT

As we endure Spring 2025, many covered entities (CEs) continue to perform their ordinary and necessary duties to operate their 340B programs.  This may include conducting an annual independent audit, financially reconciling the previous fiscal year, getting

Read More »

Minnesota Finalizes Expanded 340B Provider Reporting Requirements, Extends Submission Deadline to May 30

The Minnesota Department of Health issued updated reporting guidance last week for 340B providers.
Minnesota covered entities will have additional 340B reporting requirements this year, but an extended deadline to submit that data, according [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Sues Utah Over New 340B Contract Pharmacy Access Law

A drug industry trade group recently challenged Utah's new 340B contract pharmacy access law in the U.S. District Court for the District of Utah.
An influential drug industry trade group on Friday sued Utah over its 340B contract pharmacy access law, marking the third [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: A Powerful Statement from the Heartland

Ted Slafsky, publisher and CEO of 340B Report, writes about Nebraska's newly enacted 340B contract pharmacy access law.
On April 9th, Nebraska Gov. Jim Pillen (R) signed a comprehensive 340B contract pharmacy access law that went into effect [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Leaked HHS Budget Document Details Plans to Move 340B Program to CMS

The Trump administration appears to detail its plans to move the 340B program from HRSA to CMS in a reportedly leaked internal budget document.
President Donald Trump’s (R) preliminary budget appears to call for “new authority to regulate all aspects of the 340B program,” [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Tennessee Legislature Approves Scaled-Back Bill Barring Future Drugmaker 340B Restrictions Placed After July 2025

The Tennessee House and Senate both passed a scaled-back 340B contract pharmacy access bill on April 16 after a last-minute amendment.
Both chambers of the Tennessee Legislature yesterday passed a scaled-back contract pharmacy access bill that would block manufacturers from placing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospitals, Health Centers Criticize Trump’s Executive Order Over Controversial 340B Rule, Possible Medicare Payment Cuts

President Donald Trump (R) issued a wide-ranging April 15 executive order on drug pricing policy.
Hospital and health center leaders are pushing back against President Donald Trump’s (R) new executive order, criticizing its controversial 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Tariffs on Pharmaceuticals Could Worsen Drug Shortages, Cause Disarray in 340B Prices, Advocates Say

President Trump said he will implement tariffs on pharmaceuticals in the “not too distant future.” Many of the details of these potential tariffs remain unknown.
President Donald Trump’s (R) plan to place tariffs on foreign pharmaceuticals could destabilize 340B drugs’ prices unless drugmakers absorb the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live